Viable virus shedding during SARS-CoV-2 reinfection
- PMID: 33964243
- PMCID: PMC8099311
- DOI: 10.1016/S2213-2600(21)00219-8
Viable virus shedding during SARS-CoV-2 reinfection
Conflict of interest statement
All authors declare no competing interests. This study was supported by the Defense Health Agency and Defense Advanced Research Projects Agency. AGL, DRS, CG, DLW, HWC, RAL, SEL, JM, EN, CKP, ESA, MS, VAS, PS, and MT are military service members or government service employees. This work was prepared as part of their official duties. Title 17, US Code §105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, US code §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties. The views expressed in the article are those of the authors and do not necessarily express the official policy and position of the US Navy, the Department of Defense, the US Government, or the institutions affiliated with the authors.
Comment on
-
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.Lancet Respir Med. 2021 Jul;9(7):712-720. doi: 10.1016/S2213-2600(21)00158-2. Epub 2021 Apr 15. Lancet Respir Med. 2021. PMID: 33865504 Free PMC article.
References
-
- Ledford H. Coronavirus reinfections: three questions scientists are asking. Nature. 2020;585:168–169. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous